The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...

In this video, I will cover the recent updates regarding Novo Nordisk (NYSE: NVO). Watch the short video to learn more, ...

Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the ...

We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...

Wondering if you should look beyond American markets to build your fortune? This widely held international fund offers a few ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...